Marco ThomannSenior Scientist at Roche Diagnostics GmbH
Study of biotechnology and bioinformatics. Started at Roche in 2004 as analytical scientist (mainly mass spectrometry). Became group leader for extended characterization of drug substance in 2008 and since then focused on late stage projects, including CQA assessment, comparability exercises, regulatory filings. Furthermore, involved in extended characterization of marketed products and experienced in the in vitro glycoengineering area.